Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid During Cystectomy Trial (TACT)

NCT01869413 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01869413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid During Cystectomy Trial (TACT)
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2013
Completion date
June 30, 2021
Enrollment
354 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer